Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group Collaboration-Reference-Cited by-同舟云学术

Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group Collaboration

Published:2024-06 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Soria Francesco^ORCID,Rosazza Matteo,Livoti Simone,Moschini Marco,De Angelis Mario,Giudice Francesco Del,Pichler Renate,Hurle Rodolfo,Mancon Stefano,Carrion Diego M.,Krajewski Wojciech,Mertens Laura S.,D’Andrea David,Mari Andrea,Di Maida Fabrizio,Dutto Daniele,Colucci Fulvia,Casale Giulia,Fertitta Giorgia,Laukhtina Ekaterina,Albisinni Simone,Pradere Benjamin,Teoh Jeremy Y.C.,Shariat Shahrokh F.,Briganti Alberto,Kamat Ashish M.,Gontero Paolo

Publisher

Elsevier BV

Reference10 articles.

1. European Association of Urology guidelines on non–muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ);Babjuk;Eur Urol,2022

2. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline;Chang;J Urol,2016

3. European Association of Urology (EAU) prognostic factor risk groups for non–muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC Guidelines Panel;Sylvester;Eur Urol,2021

4. Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer;Kamat;J Urol,2014

5. Definitions, end points, and clinical trial designs for bladder cancer: recommendations from the Society for Immunotherapy of Cancer and the International Bladder Cancer Group;Kamat;J Clin Oncol,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG);European Urology Oncology;2024-08